Trial Details

COMPLETED
Basic Information
Clinical ID c1916
Identifier NCT05340764
Trial Title Safety of Reduced Infliximab Infusion Time
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Inflammatory Bowel Diseases
Interventions DRUG: Infliximab
Participant Information
Sponsor Washington University School of Medicine
City Saint Louis
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2020-08-01
Primary Completion Date 2023-05-04
Completion Date 2023-05-04